As increased PD-L1 expression in macrophages contributes to the exhaustion of CTLs, the simultaneous inhibition of the PD-1 signal in macrophages by the anti-PD-1 antibody may have synergistically enhanced the anti-tumor activity of the DSP-0509 and anti-PD-1 antibody combination. Here, CD274 is linked to neoplasm.